Statins Reduce Bleeding Risk in Patients Taking Oral Anticoagulants for Nonvalvular Atrial Fibrillation: A Retrospective Registry Study.
Kazutaka UchidaShinichiro UedaFumihiro SakakibaraNorito KinjoMari NezuHideki AraiTakeshi MorimotoPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2022)
Statins significantly reduced the risk of major bleeding, all-cause mortality, and ischemic events in patients with NVAF taking OACs. Their additive benefits should be considered in routine practice and thus be further researched.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- end stage renal disease
- direct oral anticoagulants
- cardiovascular disease
- heart failure
- newly diagnosed
- percutaneous coronary intervention
- ejection fraction
- primary care
- healthcare
- chronic kidney disease
- peritoneal dialysis
- ischemia reperfusion injury
- clinical practice
- type diabetes
- mitral valve